Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Amgen (2024) AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT AT 52 WEEKS IN A PHASE 2 STUDY [press release]
Your medication handles the appetite
Rather than encouraging cycles of yo-yo dieting, unsustainable tracking, or restrictive eating, it promotes behavioral harmony, energy awareness, and nutritional literacy
Prescribers should base decisions on clinical necessity and monitor both mother and infant when use during lactation is unavoidable
Reported side effects are rare and typically mild: Transient drowsiness or mild fatigue following administration
US$ 24.07
US$ 25.51
US$ 20.35
